For better or worse: FFAR1 and FFAR4 signaling in cancer and diabetes

作者: J. M. Houthuijzen

DOI: 10.1124/MOL.116.105932

关键词: Signal transductionInflammationProstate cancerFree fatty acid receptor 1CancerInternal medicineReceptorEndocrinologyDiabetes mellitusBiologyFatty acid

摘要: Increased energy intake can lead to obesity, which increases the risk for development of diabetes and cancer. Free fatty acids regulate numerous cellular processes, like insulin secretion, inflammation, proliferation, cell migration. Dysregulation these functions by increased lipid plays a significant role in diseases acid receptors 1 4 (FFAR1 FFAR4) are two free under increasing investigation their roles more recently also Both bind medium- long-chain, saturated omega-3 unsaturated acids. Increasing evidence shows that enhanced FFAR1 FFAR4 signaling reduces symptoms but enhances tumor growth migration various cancer types melanoma prostate This review gives an overview discusses potential function as targets treatment.

参考文章(52)
Kaori Fukushima, Eri Yamasaki, Shuhei Ishii, Ayaka Tomimatsu, Kaede Takahashi, Miku Hirane, Nobuyuki Fukushima, Kanya Honoki, Toshifumi Tsujiuchi, Different roles of GPR120 and GPR40 in the acquisition of malignant properties in pancreatic cancer cells. Biochemical and Biophysical Research Communications. ,vol. 465, pp. 512- 515 ,(2015) , 10.1016/J.BBRC.2015.08.050
Arturo D Mancini, Gyslaine Bertrand, Kevin Vivot, Éric Carpentier, Caroline Tremblay, Julien Ghislain, Michel Bouvier, Vincent Poitout, None, β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1. Journal of Biological Chemistry. ,vol. 290, pp. 21131- 21140 ,(2015) , 10.1074/JBC.M115.644450
G Milligan, E Alvarez-Curto, K R Watterson, T Ulven, B D Hudson, Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4 British Journal of Pharmacology. ,vol. 172, pp. 3254- 3265 ,(2015) , 10.1111/BPH.12879
Trond Ulven, Elisabeth Christiansen, Dietary Fatty Acids and Their Potential for Controlling Metabolic Diseases Through Activation of FFA4/GPR120 Annual Review of Nutrition. ,vol. 35, pp. 239- 263 ,(2015) , 10.1146/ANNUREV-NUTR-071714-034410
Shuhei Ishii, Yuka Kitamura, Miku Hirane, Ayaka Tomimatsu, Kaori Fukushima, Kaede Takahashi, Nobuyuki Fukushima, Kanya Honoki, Toshifumi Tsujiuchi, Negative effects of G-protein-coupled free fatty acid receptor GPR40 on cell migration and invasion in fibrosarcoma HT1080 cells. Molecular Carcinogenesis. ,vol. 55, pp. 1553- 1559 ,(2016) , 10.1002/MC.22408
Chi Shing Sum, Irina G. Tikhonova, Susanne Neumann, Stanislav Engel, Bruce M. Raaka, Stefano Costanzi, Marvin C. Gershengorn, Identification of Residues Important for Agonist Recognition and Activation in GPR40 Journal of Biological Chemistry. ,vol. 282, pp. 29248- 29255 ,(2007) , 10.1074/JBC.M705077200
Ankita Srivastava, Jason Yano, Yoshihiko Hirozane, Georgia Kefala, Franz Gruswitz, Gyorgy Snell, Weston Lane, Anthony Ivetac, Kathleen Aertgeerts, Jasmine Nguyen, Andy Jennings, Kengo Okada, High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875 Nature. ,vol. 513, pp. 124- 127 ,(2014) , 10.1038/NATURE13494
Maria Hauge, Marie A. Vestmar, Anna S. Husted, Jeppe P. Ekberg, Michael J. Wright, Jerry Di Salvo, Adam B. Weinglass, Maja S. Engelstoft, Andreas N. Madsen, Michael Lückmann, Michael W. Miller, Maria E. Trujillo, Thomas M. Frimurer, Birgitte Holst, Andrew D. Howard, Thue W. Schwartz, GPR40 (FFAR1) – Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo Molecular metabolism. ,vol. 4, pp. 3- 14 ,(2015) , 10.1016/J.MOLMET.2014.10.002
T. Araki, M. Hirayama, S. Hiroi, K. Kaku, GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes. Diabetes, Obesity and Metabolism. ,vol. 14, pp. 271- 278 ,(2012) , 10.1111/J.1463-1326.2011.01525.X
XIAO-TAO FENG, JING LENG, ZHEN XIE, SHUANG-LEI LI, WEI ZHAO, QIAN-LI TANG, GPR40: a therapeutic target for mediating insulin secretion (review). International Journal of Molecular Medicine. ,vol. 30, pp. 1261- 1266 ,(2012) , 10.3892/IJMM.2012.1142